Mucolipidosis II: novel variants, clinical variation and assessment of HAP1 cells as a disease model
Human Molecular Genetics · 10.08.2026 · 35 (17)
DOI: 10.1093/hmg/ddag068 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, online erschienen am 10.08.2026. Verfasst von Noura R Eissa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical Molecular genetics Department, Human Genetics and Genome Research Institute, National Research Centre, 33 El Buhouth St، Ad Doqi, Dokki, Cair…. Hauptthemen laut MEDLINE: Mucolipidoses, Transferases (Other Substituted Phosphate Groups). Die Arbeit nennt 47 Literaturangaben. Gefördert von: Jaeken-Theunissen CDG Fund, FWO-FNRS WEAVE program.
Abstract (Originalsprache)
Mucolipidosis type II is an autosomal recessive lysosomal storage disease resulting from biallelic variants in the GNPTAB gene encoding the N-acetylglucosamine phosphotransferase α/β subunits. Deficiency of this enzyme disrupts the mannose-6-phosphate (M6P) trafficking pathway, resulting in mistargeting of lysosomal acid hydrolases. Subsequently, lysosomal accumulation of undegraded macromolecules gives rise to a clinical phenotype with developmental/intellectual disability, skeletal deformities, coarse features, and cardiopulmonary dysfunction. Here, we report a cohort of eight patients (7 Egyptians and 1 Yemeni) from seven families with three reported homozygous pathogenic variants and three unreported variants (p.(Asn750Ilefs*4), p.(Val795Glyfs*7), and c.3602 + 2 T > C). In addition, the GNPTAB gene was ablated in the H. sapiens haploid HAP1 cells by CRISPR-Cas9 editing, to investigate the potential of this cell line for the assessment of variant pathogenicity. This included introduction of the recurrent c.3503_3504delTC variant. A phenotype of impaired autophagic flux was recapitulated, suggesting that HAP1 cells are a suitable model for this disorder.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Molecular genetics Department, Human Genetics and Genome Research Institute, National Research Centre, 33 El Buhouth St، Ad Doqi, Dokki, Cairo Governorate, 12622, Egypt.
- Academy of Scientific Research & Technology (ASRT), 101 Kasr Al-Ainy St, Cairo Governorate, 11516, Egypt.
- Clinical genetics Department, Human Genetics and Genome Research Institute, National Research Centre, 33 El Buhouth St، Ad Doqi, Dokki, Cairo Governorate, 12622, Egypt.
- Laboratory for Molecular Diagnosis, Center for Human Genetics, KU Leuven, UZ Leuven Gasthuisberg Campus, Herestraat 49, 3000 Leuven, Belgium.
- Department of Pediatrics, Center for Metabolic Diseases, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium.
ORCID-Profile: Noura R Eissa, Matthew P Wilson
Förderung
- Jaeken-Theunissen CDG Fund
- FWO-FNRS WEAVE program
Zitieren
APA
Eissa, N. R., Abdel-Salam, G. M., Kretkiewicz, M., Pieters, E., Jaeken, J., Matthijs, G., & Wilson, M. P. (2026). Mucolipidosis II: novel variants, clinical variation and assessment of HAP1 cells as a disease model. Human Molecular Genetics, 35(17). https://doi.org/10.1093/hmg/ddag068
Vancouver
Eissa NR, Abdel-Salam GM, Kretkiewicz M, Pieters E, Jaeken J, Matthijs G, et al. Mucolipidosis II: novel variants, clinical variation and assessment of HAP1 cells as a disease model. Human Molecular Genetics. 2026;35(17). doi:10.1093/hmg/ddag068
BibTeX
@article{Eissa2026,
author = {Eissa, Noura R and Abdel-Salam, Ghada M and Kretkiewicz, Marcelina and Pieters, Eline and Jaeken, Jaak and Matthijs, Gert and Wilson, Matthew P},
title = {Mucolipidosis II: novel variants, clinical variation and assessment of HAP1 cells as a disease model},
journal = {Human Molecular Genetics},
year = {2026},
volume = {35},
number = {17},
doi = {10.1093/hmg/ddag068}
}
EUVIMED